Clinical Trials Directory

Trials / Conditions / Glaucoma and Ocular Hypertension

Glaucoma and Ocular Hypertension

13 registered clinical trials studyying Glaucoma and Ocular Hypertension — 1 currently recruiting.

StatusTrialSponsorPhase
Completed24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
NCT06689696
Smartlens, Inc.—
CompletedEvaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
NCT05181046
Nanodropper, Inc.N/A
RecruitingClarifying the Optimal Application of SLT Therapy Trial
NCT04967989
University of PittsburghPhase 3
UnknownEndoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)
NCT04337944
Centre hospitalier de l'Université de Montréal (CHUM)N/A
CompletedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleat
NCT03691662
Santen Inc.Phase 3
CompletedA Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleat
NCT03691649
Santen Inc.Phase 3
CompletedEffect of Dexamethasone Implant on Optic Disc
NCT03927118
Bulent Ecevit University—
CompletedTreatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma
NCT03187418
Centre hospitalier de l'Université de Montréal (CHUM)N/A
CompletedSafety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension
NCT02371746
Envisia TherapeuticsPhase 2
TerminatedProspective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients
NCT02231515
University Hospital, GenevaN/A
UnknownCombined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract
NCT02209961
Hillel Yaffe Medical Center—
CompletedStudy Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmi
NCT01687426
Eye Therapies, LLCPhase 1
CompletedA Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT
NCT01654484
Santen Inc.Phase 1 / Phase 2